Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,961,558 papers from all fields of science
Search
Sign In
Create Free Account
Interferon Signaling Process
Known as:
Interferon Activation
Any process which promotes expression of the interferon proteins, their subsequent secretion, binding to cognate receptors or intracellular signaling…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
43 relations
2-5A-dependent ribonuclease
Aldesleukin
CIITA gene
CIITA wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Interferon signature in immunosuppressed patients with lower respiratory tract infections: dosage on bronchoalveolar lavage.
M. Bergallo
,
L. Ferrari
,
+9 authors
P. Ravanini
Minerva Medica
2019
Corpus ID: 208227766
BACKGROUND Interferon signature (IS) is the measure of transcripts belonging to pathways of interferon activation. Viral…
Expand
2016
2016
Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4.
A. Pretorius
,
F. E. Faber
,
M. Van Kleef
Immunobiology
2016
Corpus ID: 35247719
2014
2014
Omega‐3 fatty acids and/or fluvastatin in hepatitis C prior non‐responders to combination antiviral therapy – a pilot randomised clinical trial
D. Sheridan
,
S. Bridge
,
+6 authors
M. Bassendine
Liver international (Print)
2014
Corpus ID: 46067690
Hepatitis C virus (HCV) utilises cholesterol and lipoprotein metabolism for replication and infectivity. Statins and omega‐3 (n–3…
Expand
1999
1999
The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.
K. Kanda
,
B. Kempkes
,
G. Bornkamm
,
A. von Gabain
,
T. Decker
Biological chemistry
1999
Corpus ID: 43591920
Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein involved in cell transformation, interferes with the cellular response to…
Expand
1999
1999
Prolactin regulation of pim-1 expression: positive and negative promoter elements.
K. Borg
,
M. Zhang
,
+4 authors
A. Buckley
Endocrinology
1999
Corpus ID: 24343883
The lactogen-dependent rat Nb2 lymphoma is a useful model to investigate PRL signaling pathways that lead to regulation of gene…
Expand
1994
1994
A novel interferon-alpha-regulated, DNA-binding protein participates in the regulation of the IFP53/tryptophanyl-tRNA synthetase gene.
D. Seegert
,
I. Strehlow
,
B. Klose
,
D. Levy
,
C. Schindler
,
T. Decker
Journal of Biological Chemistry
1994
Corpus ID: 45369172
Review
1991
Review
1991
Do second messengers play a role in interferon signal transduction?
L. Pfeffer
,
Y. H. Tan
TIBS -Trends in Biochemical Sciences. Regular ed
1991
Corpus ID: 45553050
1986
1986
Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
C. Colmenares
,
C. López
Journal of Immunology
1986
Corpus ID: 44370050
Spontaneously cytotoxic murine lymphocytes lysed certain cell types infected by herpes simplex virus type 1 (HSV-1) better than…
Expand
Review
1985
Review
1985
Viruses and immune reactions in the liver.
H. Thomas
,
M. Pignatelli
,
L. Scully
Scandinavian Journal of Gastroenterology…
1985
Corpus ID: 25134564
The immunopathology of hepatitis B and delta virus infections of the liver are reviewed. It is clear there are several antigen…
Expand
1983
1983
Isolation of spontaneous and interferon inducible natural killer like cells from human colonic mucosa: lysis of lymphoid and autologous epithelial target cells.
S. Targan
,
L. Britvan
,
R. Kendal
,
S. Vimadalal
,
A. Soll
Clinical and Experimental Immunology
1983
Corpus ID: 34059416
Viable mononuclear and epithelial cells were dispersed from human colonic tissue by treatment with collagenase and ethylene…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE